NO900991D0 - Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(l-piperazinyl)-4-fenylcycloalkanopyridin-derivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(l-piperazinyl)-4-fenylcycloalkanopyridin-derivater

Info

Publication number
NO900991D0
NO900991D0 NO900991A NO900991A NO900991D0 NO 900991 D0 NO900991 D0 NO 900991D0 NO 900991 A NO900991 A NO 900991A NO 900991 A NO900991 A NO 900991A NO 900991 D0 NO900991 D0 NO 900991D0
Authority
NO
Norway
Prior art keywords
alkyl
piperazinyl
derivatives
preparation
hydrogen atom
Prior art date
Application number
NO900991A
Other languages
English (en)
Other versions
NO900991L (no
NO177095C (no
NO177095B (no
Inventor
Katsuhiko Hino
Naoki Kai
Masato Sakamoto
Tatsuya Kon
Makoto Oka
Kiyoshi Furukawa
Yoshiaki Ochi
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of NO900991D0 publication Critical patent/NO900991D0/no
Publication of NO900991L publication Critical patent/NO900991L/no
Publication of NO177095B publication Critical patent/NO177095B/no
Publication of NO177095C publication Critical patent/NO177095C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO900991A 1989-03-03 1990-03-01 Analogifremgangsmåte for fremstilling av terapeutisk virksomme 2-(l-piperazinyl)-4-fenylcycloalkanopyridin-derivater NO177095C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5254489 1989-03-03

Publications (4)

Publication Number Publication Date
NO900991D0 true NO900991D0 (no) 1990-03-01
NO900991L NO900991L (no) 1990-09-04
NO177095B NO177095B (no) 1995-04-10
NO177095C NO177095C (no) 1995-07-19

Family

ID=12917732

Family Applications (1)

Application Number Title Priority Date Filing Date
NO900991A NO177095C (no) 1989-03-03 1990-03-01 Analogifremgangsmåte for fremstilling av terapeutisk virksomme 2-(l-piperazinyl)-4-fenylcycloalkanopyridin-derivater

Country Status (15)

Country Link
US (1) US5021421A (no)
EP (1) EP0385237B1 (no)
KR (1) KR0149649B1 (no)
AT (1) ATE107922T1 (no)
AU (1) AU623981B2 (no)
CA (1) CA2011346C (no)
DD (1) DD292909A5 (no)
DE (1) DE69010232T2 (no)
DK (1) DK0385237T3 (no)
ES (1) ES2058630T3 (no)
FI (1) FI94413C (no)
HK (1) HK1005872A1 (no)
HU (1) HU204810B (no)
NO (1) NO177095C (no)
RU (1) RU2075478C1 (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041443A (en) * 1989-02-21 1991-08-20 Dainippon Pharmaceutical Co., Ltd. Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof
US5747493A (en) * 1993-06-25 1998-05-05 Pola Chemical Industries, Inc. Dopamine re-uptake inhibitor
CA2144669A1 (en) * 1994-03-29 1995-09-30 Kozo Akasaka Biphenyl derivatives
US6458789B1 (en) * 1999-09-29 2002-10-01 Lion Bioscience Ag 2-aminopyridine derivatives and combinatorial libraries thereof
MXPA04007612A (es) * 2002-02-05 2004-11-10 Novo Nordisk As Aril- y heteroarilpiperazinas novedosas.
MX2007012082A (es) 2005-03-31 2007-11-20 Pfizer Prod Inc Derivados de ciclopentapiridina y tetrahidroquinolina.
JP5121707B2 (ja) 2005-07-04 2013-01-16 ハイ ポイント ファーマシューティカルズ,エルエルシー 新規医薬
JP2009537596A (ja) 2006-05-23 2009-10-29 ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー 6−(4−シクロプロピルピペリジン−1−イル)−2’−メチル−[3,4’]−ビピリジン及びその医薬としての使用
SG163547A1 (en) 2006-05-29 2010-08-30 High Point Pharmaceuticals Llc 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
JP5001271B2 (ja) * 2006-06-09 2012-08-15 大日本住友製薬株式会社 新規テープ製剤
US20090192143A1 (en) * 2006-07-14 2009-07-30 Cox Christopher D Substituted diazepan orexin receptor antagonists
EP2578216A1 (en) 2006-11-22 2013-04-10 Seaside Therapeutics, Inc. Methods of treating fragile x syndrome
EP2014656A3 (en) 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
CN101531634B (zh) * 2008-03-10 2013-09-18 北京德众万全医药科技有限公司 一种高纯度的布南色林及其制备方法
CN101530412A (zh) * 2008-03-10 2009-09-16 北京德众万全医药科技有限公司 一种布南色林的药物组合物及其制备方法
CN101747272B (zh) * 2008-12-02 2012-11-28 浙江华海药业股份有限公司 布南色林晶型b及其制备方法
CN101747273B (zh) * 2008-12-02 2012-03-07 浙江华海药业股份有限公司 布南色林中间体的制备方法
CN101766626B (zh) * 2008-12-30 2012-03-07 丽珠医药集团股份有限公司 一种治疗精神分裂症的含布南色林的口服制剂
WO2010105243A1 (en) 2009-03-13 2010-09-16 Agios Pharmaceuticals, Inc. Methods and compositions for cell-proliferation-related disorders
IN2012DN00471A (no) 2009-06-29 2015-06-05 Agios Pharmaceuticals Inc
CN101619039B (zh) * 2009-06-30 2011-04-13 严洁 2-(4-乙基-1-哌嗪基)-4-(4-氟苯基)-5,6,7,8,9,10-六氢芳辛并[b]吡啶及其组合物
EP2525790B1 (en) 2009-10-21 2020-05-27 Agios Pharmaceuticals, Inc. Methods and compositions for cell-proliferation-related disorders
EP2491145B1 (en) 2009-10-21 2016-03-09 Agios Pharmaceuticals, Inc. Methods and compositions for cell-proliferation-related disorders
EP2603207A2 (en) 2010-08-10 2013-06-19 Lupin Limited Oral controlled release pharmaceutical compositions of blonanserin
CN102372673B (zh) * 2010-08-27 2014-04-09 天津市医药集团技术发展有限公司 布南色林结晶及其制备方法
CN102093289B (zh) * 2010-10-29 2012-12-19 常州华生制药有限公司 布南色林中间体的制备方法
CN102030707A (zh) * 2010-11-12 2011-04-27 深圳万和制药有限公司 布南色林中间体的制备方法
RU2675656C2 (ru) 2011-05-03 2018-12-21 Аджиос Фармасьютикалз, Инк. Способы применения активаторов пируваткиназы
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827170A (zh) * 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN115536635A (zh) 2012-01-06 2022-12-30 法国施维雅药厂 治疗活性化合物及其使用方法
US9474779B2 (en) 2012-01-19 2016-10-25 Agios Pharmaceuticals, Inc. Therapeutically active compositions and their methods of use
NZ706999A (en) 2012-10-15 2018-12-21 Agios Pharmaceuticals Inc Inhibitors of mutant isocitrate dehydrogenase and therapeutical uses thereof
WO2015003360A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
WO2015003355A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
EP3019480B1 (en) 2013-07-11 2020-05-06 Agios Pharmaceuticals, Inc. 2,4- or 4,6-diaminopyrimidine compounds as idh2 mutants inhibitors for the treatment of cancer
US9579324B2 (en) 2013-07-11 2017-02-28 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
US20150031627A1 (en) 2013-07-25 2015-01-29 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
NZ723859A (en) 2014-03-14 2023-01-27 Servier Lab Pharmaceutical compositions of therapeutically active compounds and their uses
CN104311487B (zh) * 2014-09-22 2016-08-24 江苏正大丰海制药有限公司 一种布南色林晶型及其制备方法
DK3307271T3 (da) 2015-06-11 2023-10-09 Agios Pharmaceuticals Inc Fremgangsmåder til anvendelse af pyruvatkinase-aktivatorer
WO2017066566A1 (en) 2015-10-15 2017-04-20 Agios Pharmaceuticals, Inc Combination therapy for treating malignancies
PT3362066T (pt) 2015-10-15 2021-11-16 Celgene Corp Terapia de combinação para tratar malignidades
KR20190028109A (ko) 2017-09-08 2019-03-18 연성정밀화학(주) 블로난세린 함유 서방성 제제
CN110575438A (zh) * 2018-06-07 2019-12-17 湖南省湘中制药有限公司 一种布南色林固体分散体的制备及其应用
US10980788B2 (en) 2018-06-08 2021-04-20 Agios Pharmaceuticals, Inc. Therapy for treating malignancies
KR20210139317A (ko) 2019-03-13 2021-11-22 오츠카 세이야쿠 가부시키가이샤 2급 아민을 함유하는 화합물의 아민 부분에 중수소 저급 알킬을 도입하는 방법
CN113698346A (zh) * 2020-05-22 2021-11-26 湖南省湘中制药有限公司 一种布南色林工艺杂质b的制备方法
CN113698347A (zh) * 2020-05-22 2021-11-26 湖南省湘中制药有限公司 一种布南色林工艺杂质f的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54128588A (en) * 1978-03-29 1979-10-05 Dainippon Pharmaceut Co Ltd Antidepressive drugs consisting mainly of 2-(1-piperazinyl)- 4-phenylquinoline
DE3124673A1 (de) * 1981-06-24 1983-01-13 Bayer Ag, 5090 Leverkusen Subsituierte 2-amino-pyridinderivate, verfahren zu ihrer herstellung, ihre verwendung in arzneimitteln, sowie deren herstellung
FR2602771B1 (fr) * 1986-08-12 1988-11-04 Rhone Poulenc Sante Nouveaux derives de la benzyl-4 piperazine, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
DE69010232T2 (de) 1994-12-01
NO900991L (no) 1990-09-04
FI94413C (fi) 1995-09-11
US5021421A (en) 1991-06-04
KR900014358A (ko) 1990-10-23
HUT53361A (en) 1990-10-28
DE69010232D1 (de) 1994-08-04
HU901275D0 (en) 1990-05-28
FI901030A0 (fi) 1990-03-01
HU204810B (en) 1992-02-28
FI94413B (fi) 1995-05-31
HK1005872A1 (en) 1999-01-29
AU5060490A (en) 1990-09-06
EP0385237A3 (en) 1991-03-20
ES2058630T3 (es) 1994-11-01
NO177095C (no) 1995-07-19
EP0385237B1 (en) 1994-06-29
ATE107922T1 (de) 1994-07-15
RU2075478C1 (ru) 1997-03-20
KR0149649B1 (ko) 1998-10-15
DD292909A5 (de) 1991-08-14
CA2011346C (en) 1999-08-03
EP0385237A2 (en) 1990-09-05
NO177095B (no) 1995-04-10
AU623981B2 (en) 1992-05-28
DK0385237T3 (da) 1994-07-25
CA2011346A1 (en) 1990-09-03

Similar Documents

Publication Publication Date Title
NO900991D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(l-piperazinyl)-4-fenylcycloalkanopyridin-derivater
RU2403251C2 (ru) Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70
BR9908764A (pt) Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica
NO902214D0 (no) Fremgangsmaate for fremstilling av n-(aryloksyalkyl)-heteroarylpiperidiner og -heteroarylpiperaziner og deres anvendelse som medikamenter.
NO904134D0 (no) Fremgangsmaate for fremstilling av pyrazolderivater.
ATE79376T1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE52498T1 (de) Amidderivate.
FR2800735B1 (fr) Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation
DK0474243T3 (da) 1-methylcarbapenemderivater og fremgangsmåde til fremstilling deraf
KR910007883A (ko) 퀴놀린 유도체, 그의 제조방법 및 용도
KR960022486A (ko) 신규 티아졸리딘-4-온 유도체
NO882334D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO171786C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
FR2612517B1 (fr) Derives de benzoxazine, procedes de preparation de ces derives et compositions pharmaceutiques les contenant
KR910000755A (ko) 세로토닌 2-수용체 길항활성을 갖는 헤테로사이클릭 화합물
NZ238571A (en) N-benzyl-n'-phenyl and -phenalkyl thioureas and pharmaceutical compositions thereof
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
DE69002340T2 (de) Pyrimidin-Derivate, 2-[4-(Alpha-heteroaryl-alpha-aryl-(alpha-alkyl)-methoxy)-butyl)-1-piperazinyl] mit serotoninergischer Wirkung.
PT96123A (pt) Metodo de preparacao de um medicamento para tratamento da infeccao do pneumocystis carinii
NO903084D0 (no) Farmasoeytisk anvendbare thiazol-derivater og fremgangsmaate for deres fremstilling.
IL97611A (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
TH15829A (th) อนุพันธ์คาร์โบสไทริล
MX9703074A (es) Inhibidores de sintesis de apoliproteina-b.

Legal Events

Date Code Title Description
MK1K Patent expired